How Can Erythropoeitin-Stimulating Agent Use be Reduced in Chronic Dialysis Patients?

Can Reduction of Inflammation Improve ESA Dose Response?


  • Csaba P Kovesdy

    Corresponding author
    • Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center and Memphis VA Medical Center, Memphis, Tennessee
    Search for more papers by this author

Address correspondence to: Csaba P Kovesdy, MD FASN, Division of Nephrology, Memphis VA Medical Center, 1030 Jefferson Ave., Memphis, TN 38104, Tel.: 901-577-7278, Fax: 901-577-7539, or e-mail:

No abstract is available for this article.